Oncology

Latest News

The findings can help guide ongoing and future clinical trials to help solve remaining challenges in LS-SCLC. | Image credit: Jennifer - stock.adobe

Neoadjuvant Immunotherapy Plus Chemotherapy Shows Promise in LS-SCLC

By Jared Kaltwasser

August 31st 2025

The findings may inform future studies on the therapeutic strategy for patients with small cell lung cancer (SCLC).

PD-1 blockade has previously shown success in a first-line setting in ES-SCLC, and nab-paclitaxel is albumin-bound and solvent-free, which the investigators explained may minimize the toxicity associated with paclitaxel therapy. | Image credit: didesign - stock.adobe.com

Camrelizumab Plus Carboplatin, Nab-Paclitaxel Shows Efficacy in ES-SCLC

By Jared Kaltwasser

August 29th 2025

For rent sign | Image Credit: David Gales - stock.adobe.com

Housing Assistance May Help Renters With Cancer Better Withstand Medical Financial Strain

By Brooke McCormick

August 28th 2025

Patient with cancer undergoing chemotherapy | Image credit: RFBSIP – stock.adobe.com

Many Patients With Advanced Cancer Report Care Misaligned With Their Goals

By Hayden E. Klein

August 25th 2025

Innovation vs Affordability: Cancer Care’s Cost Crisis and Access Gap

By Cameron Santoro

August 21st 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Watch Now

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

Continuing Medical Education

View All

September 1st 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

September 1st 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

August 21st 2014

Faster MRI Technique Comparable to the Conventional Screen

August 21st 2014

Achieving Value in Cancer Care-the Case of Low- and Middle-Income Countries

Ajay Aggarwal, MD Richard Sullivan, MD, PhD

Commentary

August 21st 2014

The Global Perspective on Value in Cancer Care

Based on presentations by Elisabeth De Vries, MD, PhD Richard Sullivan, MD, PhD Lowell E. Schnipper, MD

August 21st 2014

Overdiagnosis and Overtreatment: The Cancer Paradigm

Based on presentations by Barbara L. Smith, MD, PhD Rina S. Punglia, MD, MPH Laura Esserman, MD, MBA,

August 21st 2014

In Conversation With ASCO President Peter Paul Yu

Nicole Beagin

August 21st 2014

Clinical Pathway Adherence and Barriers to Coverage

Poster Roundup

August 20th 2014

NICE Turns Around to Support the Use of Celgene's Revlimid

The cost regulator for the NHS in England and Wales has said that Celgene's Revlimid should be an option for treating patients with a particular form of myelodysplastic syndromes.

August 20th 2014

ASCO President Peter P. Yu on Attending AJMC's Patient-Centered Oncology Care Meeting

Peter Paul Yu, MD, FASCO, who this summer became president of the American Society of Clinical Oncology, shared how the group is leading the discussion of what constitutes value in cancer care, as well as the need to engage all stakeholders in this critical topic.

August 20th 2014

Cancer Care in the United States: The Path Ahead

Surabhi Dangi-Garimella, PhD

August 20th 2014

The EGF Receptor (EGFR) Continues to Be a Promising Target in NSCLC

Based on presentations by Pasi A. Janne, MD, PhD Lecia V. Sequist, MD, MPH Gideon Michael Blumenthal, MD Lawrence H. Schwartz, MD

August 20th 2014

BMS and Celgene Announce Collaboration on An Immuno-Chemo Combination Regimen

Combining nab-paclitaxel with nivolumab is expected to have a synergistic effect in the various tumor types to be targeted, while providing Celgene access to the immunooncology race.

August 19th 2014

NIH Initiates ALCHEMIST Trials: Targeted Treatment in Early-Stage Lung Cancer

The trials will evaluate the efficacy of erlotinib or crizotinib in preventing lung cancer recurrence, as well as survival, in patients carrying mutations in either EGFR or ALK, who are clinically free of the disease.

August 19th 2014

Raising Awareness for Treating Adult Survivors of Childhood Cancers

Guidelines, such as those developed by the Children's Oncology Group, can prove a useful resource to monitor and/or treat adults who have previously been treated for a pediatric cancer.

August 19th 2014

Studies Point to Unnecessary Testing in Cancer, Particularly in the Older Population

The two studies, published in the August issue of JAMA Internal Medicine, examine the pros and cons of the current cancer screening methodologies.

August 18th 2014

Editorial: Can Gene Signatures Tell Us All?

The writer asks: is more information better, even if we don't understand what it means?

August 18th 2014

BRCA2 Mutation: Poor Prognosis in Prostate Cancer

The study, published in the British Journal of Cancer, observed poor survival at the end of the follow-up period in men carrying the mutation, compared to non-carriers.

August 18th 2014

Model Evaluates Efficient Use of the PSA Test

The analysis recommends conducting the PSA test in those less than 70 years of age, to avoid overdiagnosis while reducing death by at least 50%.

August 17th 2014

American Cancer Society Releases Guide for Prostate Cancer Survivor Management

August 16th 2014

Two Leading Cancer Organizations, ASCO and AACR, Take a Stand on E-Cigarettes

ASCO and AACR want to see stricter regulation of the products, touching various aspects such as flavors, child-proofing, refills etc.

August 15th 2014

Medicare Proposes Covering Newly Approved Cologuard Test for CRC Detection

The final decision on the proposal will be made only after a 30-day comment period.

August 15th 2014

"Value" Decision by NICE Met With Disapproval

Both, the scientific community and a charitable organization, Prostate Cancer UK, have criticized the drug approval body for not offering abiraterone to sufferers until after chemotherapy.

August 14th 2014

Fifteen-Year Study Identifies BMI as a Risk Factor for Ten Cancers

The study, published in Lancet, reaffirms that being obese and overweight can be a major health burden and can lead to various other diseases.

August 14th 2014

Amgen's Kyprolis Fails in Phase 3 MM Trial

Kyprolis failed to improve survival in the phase 3 FOCUS trial in patients who had relapse following at least 3 prior regimens.

August 13th 2014

Blood Test Could Detect DNA from Cancerous Cells: A Liquid Biopsy

Scientists at Hopkins are working on developing a test that can rapidly sequence cellular DNA in a blood sample for early diagnosis of cancer, which could have a tremendous potential in asymptomatic subtypes of the disease.

August 13th 2014

CMS Working on a New Oncology Payment Model

CMS provided COA a draft of an episode-based payment model being developed at their Innovation Center. COA has been in collaboration with CMS on developing this model.

August 13th 2014

Lin28b Identified As a Key Gene Responsible for Childhood Cancers

The gene, normally expressed only in a developing embryo, was found expressed in several different childhood cancers.

August 13th 2014

Wikipedia-The Next WebMD?

With the aim to authenticate and regulate medical information, Cancer Research UK plans to provide the most up-to-date and accurate healthcare information.

August 12th 2014

Cologuard Receives FDA Nod for CRC Diagnosis

Cologuard had received recommendation for premarket approval from a FDA advisory panel back in March.

August 12th 2014

Poor Cancer Outcomes Among the Uninsured and those on Medicaid

The study, published in the Journal of Clinical Oncology, examined national statistics for the period between 2007 to 2010 for people aged 18-64 of age.

August 12th 2014

Kaiser Permanente Study Confirms Efficacy of Shingles Vaccine Post-Chemotherapy

...

157 158 159 160 161 162 163 164 165

...

188 >